IFN-γ down-regulates ABCA1 expression by inhibiting LXRα in a JAK/STAT signaling pathway-dependent manner

Hansson, 1989, Detection of activated T lymphocytes in the human atherosclerotic plaque, Am J Pathol, 135, 169 Hansson, 1997, Cell-mediated immunity in atherosclerosis, Curr Opin Lipidol, 8, 301, 10.1097/00041433-199710000-00009 Libby, 1996, Macrophages and atherosclerotic plaque stability, Curr Opin Lipidol, 7, 330, 10.1097/00041433-199610000-00012 Tall, 1998, An overview of reverse cholesterol transport, Eur Heart J, 19, A31 Li, 1993, An atherogenic diet rapidly induces VCAM-I, a cytokine-regulatable mononuclear leukocyteadhesion molecule, in rabbit aortic endothelium, Arterioscler Thromb, 13, 197, 10.1161/01.ATV.13.2.197 Jonasson, 1985, Expression of class II transplantation antigen on vascular smooth muscle cells in human atherosclerosis, J Clin Invest, 76, 125, 10.1172/JCI111934 Zuckerman, 2000, The effect of gamma-interferon to inhibit macrophage-high density lipoprotein interactions is reversed by 15-deoxy-delta-12,14 prostaglandin J2, Lipids, 35, 1239, 10.1007/s11745-000-0640-9 Li, 1995, Regulation of smooth muscle cell scavenger receptor expression in vivo by atherogenic diets and in vitro by cytokines, J Clin Invest, 95, 122, 10.1172/JCI117628 Geng, 1992, Interferon-γ inhibits scavenger receptor expression and foam cell formation in human monocyte-derived macrophages, J Clin Invest, 89, 1322, 10.1172/JCI115718 Panousis, 2000, Regulation of cholesterol distribution in macrophage-derived foam cells by interferon-γ, J Lipid Res, 41, 75, 10.1016/S0022-2275(20)32076-9 Brand, 1993, Interferon-gamma inhibits macrophage apolipoprotein E production by posttranslational mechanisms, J Clin Invest, 91, 2031, 10.1172/JCI116425 Zuckerman, 1992, Cytokine regulation of macrophage apo E secretion: opposing effects of GM-CSF and TGF-α, Atherosclerosis, 96, 203, 10.1016/0021-9150(92)90066-P Panousis, 2000, Reduction of cholesterol efflux to free apolipoprotein AI by interferon gamma is associated with the downregulation of the expression of the Tangier's disease gene ABC1, Arterioscler Thromb Vasc Biol, 20, 1565, 10.1161/01.ATV.20.6.1565 Gupta, 1997, IFN-γ potentiates atherosclerosis in apoE knock-out mice, J Clin Invest, 99, 2752, 10.1172/JCI119465 Oram, 2002, The cholesterol mobilizing transporter ABCA1 as a new therapeutic target for cardiovascular disease, Trends Cardiovasc Med, 12, 170, 10.1016/S1050-1738(02)00159-7 Oram, 2002, ATP-binding cassette transporter A1 and cholesterol trafficking, Curr Opin Lipidol, 13, 373, 10.1097/00041433-200208000-00004 Oram, 2002, Molecular basis of cholesterol homeostasis: lessons from Tangier disease and ABCA1, Trends Mol Med, 8, 168, 10.1016/S1471-4914(02)02289-X Francone, 2002, ABCA1: regulation, function and relationship to atherosclerosis, Curr Opin Invest Drugs, 3, 415 Brewer, 2004, Regulation of plasma high-density lipoprotein levels by the ABCA1 transporter and the emerging role of high-density lipoprotein in the treatment of cardiovascular disease, Arterioscler Thromb Vasc Biol, 24, 1755, 10.1161/01.ATV.0000142804.27420.5b von Eckardstein, 2005, Current understanding of the metabolism and biological actions of HDL, Curr Opin Clin Nutr Metab Care, 8, 147, 10.1097/00075197-200503000-00007 Oram, 2000, ABCA1 is the cAMP inducible apolipoprotein receptor that mediates cholesterol secretion from macrophages, J Biol Chem, 275, 34508, 10.1074/jbc.M006738200 Panousis, 2001, TGF-β increases cholesterol efflux and ABC-1 expression in macrophage-derived foam cells, J Lipid Res, 42, 856, 10.1016/S0022-2275(20)31648-5 Kisseleva, 2002, Signaling through the JAK/STAT pathway, recent advances and future challenges, Gene, 285, 1, 10.1016/S0378-1119(02)00398-0 Verma, 2003, Jak family of kinases in cancer, Cancer Metastasis Rev, 22, 423, 10.1023/A:1023805715476 Rane, 2000, Janus kinases: components of multiple signaling pathways, Oncogene, 19, 5662, 10.1038/sj.onc.1203925 Leonard, 1998, Jaks and STATs: biological implications, Annu Rev Immunol, 16, 293, 10.1146/annurev.immunol.16.1.293 Chatti, 2004, Tyrosine phosphorylation of the Janus kinase 2 activation loop is essential for a high-activity catalytic state but dispensable for a basal catalytic state, Biochemistry, 43, 4272, 10.1021/bi036109b Qing, 2004, Alternative activation of STAT1 and STAT3 in response to interferon-γ, J Biol Chem, 279, 41679, 10.1074/jbc.M406413200 Lo, 2003, Constitutively active G16 stimulates STAT3 via a c-Src/JAK- and ERK-dependent mechanism, J Biol Chem, 278, 52154, 10.1074/jbc.M307299200 Rane, 2002, JAKs, STATs and Src kinases in hematopoiesis, Oncogene, 21, 3334, 10.1038/sj.onc.1205398 Darnell, 1997, STATs and gene regulation, Science, 277, 1630, 10.1126/science.277.5332.1630 Bhattacharjee, 2006, Monocyte 15-lipoxygenase expression is regulated by a novel cytosolic signaling complex with protein kinase C and tyrosine-phosphorylated STAT3, J Immunol, 177, 3771, 10.4049/jimmunol.177.6.3771 Decker, 1997, GAS elements: a few nucleotides with a major impact on cytokine-induced gene expression, J Interferon Cytokine Res, 17, 121, 10.1089/jir.1997.17.121 Kessler, 1988, Two interferon-induced nuclear factors bind a single promoter element in interferon-stimulated genes, Proc Natl Acad Sci U S A, 85, 8521, 10.1073/pnas.85.22.8521 Yang, 1998, STAT3 complements defects in an interferon-resistant cell line: evidence for an essential role for STAT3 in interferon signaling and biological activities, Proc Natl Acad Sci U S A, 95, 5568, 10.1073/pnas.95.10.5568 Yang, 2007, Identification of CXCL11 as a STAT3-dependent gene induced by IFN, J Immunol, 178, 986, 10.4049/jimmunol.178.2.986 Lawn, 1999, The Tangier disease gene product ABC1 controls the cellular apolipoprotein-mediated lipid removal pathway, J Clin Invest, 104, 25, 10.1172/JCI8119 Tang, 2004, Effect of apolipoprotein A-I on ATP binding cassette transporter A1 degradation and cholesterol efflux in THP-1 macrophage-derived foam cells, Acta Biochim Biophys Sin (Shanghai), 36, 218, 10.1093/abbs/36.3.218 Whitney, 2001, Receptor (LXR) regulation of the LXRα gene in human macrophages, J Biol Chem, 276, 43509, 10.1074/jbc.M106155200 Kim, 1996, Regulation of IFN-γ-activated STAT1 by the ubiquitin-proteasome pathway, Science, 273, 1717, 10.1126/science.273.5282.1717 Sareila, 2006, JAK inhibitors AG-490 and WHI-P154 decrease IFN-γ-induced iNOS expression and NO production in macrophages, Mediators Inflamm, 16161, 1, 10.1155/MI/2006/16161 Ivashkiv, 2004, Signaling by STATs, Arthritis Res Ther, 6, 159, 10.1186/ar1197 Blanchette, 2003, Signalling events involved in interferon-gamma-inducible macrophage nitric oxide generation, Immunology, 108, 513, 10.1046/j.1365-2567.2003.01620.x Martinez-Lostao, 2005, Role of the STAT1 pathway in apoptosis induced by fludarabine and JAK kinase inhibitors in B-cell chronic lymphocytic leukemia, Leuk Lymphoma, 46, 435, 10.1080/10428190400018398 Oram, 2002, ABCA1: the gatekeeper for eliminating excess tissue cholesterol, J Lipid Res, 42, 1173, 10.1016/S0022-2275(20)31566-2 Tang, 2004, Oxidized LDL upregulated ATP binding cassette transporter-1 in THP-1 macrophages, Acta Pharmacol Sin, 25, 581 Tang, 2003, Effects of oleate on ATP binding cassette transporter A1 expression and cholesterol efflux in THP-1 macrophage-derived foam cells, Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai), 35, 1077 Dai, 2007, Effect of T0901317 on hepatic proinflammatory gene expression in apoE−/− mice fed a high-fat/high-cholesterol diet, Inflammation, 30, 105, 10.1007/s10753-007-9026-2 Dai, 2008, The effect of T0901317 on ATP-binding cassette transporter A1 and Niemann-Pick type C1 in apoE−/− mice, J Cardiovasc Pharmacol, 51, 467, 10.1097/FJC.0b013e31816a5be3 Tontonoz, 2003, Liver X receptor signaling pathways in cardiovascular disease, Mol Endocrinol, 17, 985, 10.1210/me.2003-0061 Dai, 2008, A synthetic LXR agonist T0901317 inhibits semicarbazide-sensitive amine oxidase gene expression and activity in ApoE−/− mice, Acta Biochim Biophys Sin, 40, 261, 10.1111/j.1745-7270.2008.00391.x Walcher, 2006, LXR activation reduces proinflammatory cytokine expression in human CD4-positive lymphocytes, Arterioscler Thromb Vasc Biol, 26, 1022, 10.1161/01.ATV.0000210278.67076.8f Platanias, 2005, Mechanisms of type-I- and type-II-inter-feronmediated signalling, Immunology, 5, 375 Gatto, 2004, Analysis of SOCS-3 promoter responses to interferon gamma, J Biol Chem, 279, 13746, 10.1074/jbc.M308999200 Schmitz, 2001, Structure, function and regulation of the ABC1 gene product, Curr Opin Lipidol, 12, 129, 10.1097/00041433-200104000-00006 Costet, 2000, Sterol-dependent transactivation of the ABC1 promoter by the liver X receptor/retinoid X receptor, J Biol Chem, 275, 28240, 10.1074/jbc.M003337200 Schwartz, 2000, ABC1 gene expression and apoA-mediated cholesterol efflux are regulated by LXR, Biochem Biophys Res Commun, 274, 794, 10.1006/bbrc.2000.3243 Liao, 2002, Native LDL upregulation of ATP-binding cassette transporter-1 in human vascular endothelial cells, Arterioscler Thromb Vasc Biol, 22, 127, 10.1161/hq1201.101772 Fu, 2001, 27-Hydroxycholesterol is an endogenous ligand for liver X receptor in cholesterol-loaded cells, J Biol Chem, 276, 38378, 10.1074/jbc.M105805200 Porsch-Ozcurumez, 2001, The zinc finger protein 202 (znf202) is a transcriptional repressor of ATP binding cassette transporter a1 (abca1) and abcg1 gene expression and a modulator of cellular lipid efflux, J Biol Chem, 276, 12427, 10.1074/jbc.M100218200 Meydan, 1996, Inhibition of acute lymphoblastic leukaemia by a Jak-2 inhibitor, Nature (Lond), 379, 645, 10.1038/379645a0 Wang, 1999, JAK3. STAT, and MAPK signaling pathways as novel molecular targets for the tyrphostin AG-490 regulation of IL-2-mediated T cell response, J Immunol, 162, 3897, 10.4049/jimmunol.162.7.3897 Koeffler, 1986, Human acute myeloid leukemia lines: models of leukemogenesis, Semin Hematol, 23, 233 Auwerx, 1991, The human leukemia cell line THP-1: a multifaceted model for the study of monocyte-macrophage differentiation., Experientia, 47, 22, 10.1007/BF02041244